|
2024
|
G/S
|
pharmaceutical preparations, namely, anti-infectives and antivirals providing medical information... |
|
|
G/S
|
pharmaceutical preparations; human vaccine preparations providing medical information in the fiel... |
|
|
G/S
|
Pharmaceutical preparations, namely, anti-infectives and antivirals providing medical information... |
|
|
Invention
|
Enzymatic synthesis of 4'-ethynyl nucleoside analogs.
The present invention relates to an enzyma... |
|
|
Invention
|
Preparation of oxindole derivatives as novel diacylglyceride o-acyltransferase 2 inhibitors.
Inv... |
|
|
G/S
|
Pharmaceutical preparations, namely, anti-infectives and antivirals |
|
|
Invention
|
Identifying biosynthetic gene clusters.
A biosynthetic gene cluster (BGC) prediction system iden... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central ner... |
|
|
Invention
|
Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates... |
|
|
Invention
|
Solid dosage formulations of an orexin receptor antagonist.
The present invention is directed to... |
|
|
Invention
|
Antibody neutralizing human respiratory syncytial virus.
The present invention relates to monocl... |
|
|
Invention
|
Il4i1 inhibitors and methods of use. Described herein are compounds of Formula I or a pharmaceuti... |
|
|
Invention
|
Controlled release pde10a formulations. NSSS)-2-(5-methylpyridin-2-yl)cyclopropyl)methoxy)pyrimid... |
|
|
Invention
|
Compounds targeting mutations in p53 and uses thereof. The present disclosure relates to compound... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of respiratory, gynecological, and neurological dis... |
|
|
Invention
|
Formulations comprising actriia protein variants. In certain aspects, the present disclosure prov... |
|
|
Invention
|
Modified short inerfering nucleic acid (sina) molecules and uses thereof. OO-methyl nucleotides a... |
|
|
Invention
|
Anti-tl1a antibody compositions and methods of treatment for sarcoidosis. Described herein are hu... |
|
|
Invention
|
Alpha-synuclein binders and methods of use. in vivoin vivo to allow diagnosis of Parkinson's Dise... |
|
|
Invention
|
Pnpla3-targeting short interfering rna (sirna) molecules and uses thereof. Disclosed herein are s... |
|
|
Invention
|
Intracellular delivery of compounds in multiplexed cell-based assays. e.g.e.g., microfluidic vort... |
|
|
Invention
|
Methods for treating non-small cell lung cancer with anti-pd-1 antibodies. The invention relates ... |
|
|
Invention
|
Plasma kallikrein inhibitors. The present invention provides a compound of Formula I and pharmace... |
|
|
Invention
|
Alpha-synuclein binders and methods of use. in vivo in vivo to allow diagnosis of Parkinson's Dis... |
|
|
Invention
|
Adjuvant formulations including low viscosity chitosan or chitosan derivatives. The invention rel... |
|
|
Invention
|
Cyclic peptides for inhibiting tnf receptor 1 activity.
Provided are compounds of the Formula (I... |
|
|
Invention
|
Cyclic peptides for inhibiting tnf receptor 1 activity. The disclosure also relates to methods fo... |
|
|
Invention
|
Formulations comprising actriia polypeptide variants. In certain aspects, the present disclosure ... |
|
|
Invention
|
Prodrugs of 4'-substituted nucleoside reverse transcriptase inhibitors.
The present invention is... |
|
|
Invention
|
Syringe having force-modulating components. A proximal subassembly for an injection device includ... |
|
|
Invention
|
Prodrugs of 4'-substituted nucleoside reverse transcriptase inhibitors. The present invention is ... |
|
|
Invention
|
N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium chan... |
|
|
Invention
|
Protease inhibitors for treating or preventing coronavirus infection. 12345677, and subscripts X ... |
|
2023
|
G/S
|
Providing medical information relating to cancer Personal support services for cancer patients, n... |
|
|
Invention
|
Preparation of fused azole derivatives as novel diacylglyceride 0-acyltransferase 2 inhibitors.
... |
|
|
Invention
|
Process for preparing beta 3 agonists and intermediates.
The application is directed to efficien... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of cancer |
|
|
G/S
|
Pharmaceutical preparations for use in Oncology |
|
|
Invention
|
Anti-folr1 immunoconjugates and anti-pd-1 antibody combinations.
Therapeutic combinations of imm... |
|
|
G/S
|
Human vaccine preparations |
|
|
G/S
|
Pharmaceutical preparations and substances for use in Oncology |
|
|
G/S
|
providing medical information relating to oncology |
|
|
G/S
|
Human vaccine preparations. |
|
|
Invention
|
Static multiomic seed approach for identifying molecular signatures.
Disclosed is a method for o... |
|
2022
|
Invention
|
Cyclohexylgycine derivatives as selective cytotoxic agents.
The present disclosure is directed t... |
|
|
Invention
|
Organoid microinjection system and apparatus.
A microinjection system and apparatus comprising s... |
|
|
Invention
|
Dosage regimen for administration of belzutifan.
The present disclosure provides a method of tre... |
|
|
Invention
|
Il-2 muteins for treating cancer or infection.
Provided herein are IL-2 muteins that bind to the... |
|
|
Invention
|
Il4i1 inhibitors and methods of use.
Described herein are compounds of Formula I or a pharmaceut... |
|
|
Invention
|
Functional cell-based potency assay for measuring biological activity of interleukin 2 (il-2) ana... |
|
|
Invention
|
Synthesis of btk inhibitor and intermediates thereof.
The present invention relates to efficient... |
|
|
Invention
|
Transaminase enzymes for the transamination of (1s,5r)-6,8-dioxabicyclo[3.2.1]octan-4-one.
The p... |
|
|
Invention
|
Methods of treatment of cancer patients having altered setd2 biomarker with a pd-1 antagonist.
T... |
|
|
Invention
|
Aryl 3-oxopiperazine carboxamides and heteroaryl 3-oxopiperazine carboxamides as nav1.8 inhibitor... |
|
|
Invention
|
Il4i1 inhibitors and methods of use.
The invention discloses a synthesizing method of benzimidaz... |
|
|
Invention
|
Small molecule inhibitors of kras g12c mutant.
Compounds of Formula (I) or (Ia) or their pharmac... |
|
|
Invention
|
Small molecule inhibitors of kras g12c mutant.
Compounds or their pharmaceutically acceptable sa... |
|
|
Invention
|
Small molecule inhibitors of kras g12d mutant.
Compounds or their pharmaceutically acceptable sa... |
|
|
Invention
|
Methods for treating cancer with anti-ilt3 antibodies.
This disclosure relates to methods for tr... |
|
|
Invention
|
Heteroaryl amides as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof.
The presen... |
|
|
Invention
|
Antibodies that bind metapneumovirus, antigenic metapneumovirus proteins, and uses thereof.
The ... |
|
2021
|
Invention
|
Insulin receptor partial agonists.
Insulin dimers and insulin analog dimers that act as partial ... |
